Radio-Frequency Ablation in Cirrhotic Patients with Hepatocellular Carcinoma

Arch-Ferrer, J. E.; Smith, J. K.; Bynon, S.; Eckhoff, D. E.; Sellers, M. T.; Bland, K. I.; Heslin, M. J.
December 2003
American Surgeon;Dec2003, Vol. 69 Issue 12, p1067
Academic Journal
Current surgical treatments for hepatocellular carcinoma (HCC) include radio-frequency ablation (RFA), resection, and orthotropic liver transplant (OLT). RFA is particularly attractive in these high-risk patients because surgery is associated with high mortality and there is a relative scarcity of organs available for those in need of transplants. This study was performed to evaluate the management of cirrhotic patients with HCC undergoing RFA at a single Western institution. A retrospective study from March 1999 to June 2002 was performed to evaluate the clinicopathologic and treatment-related variables in cirrhotic patients with HCC. Forty-nine lesions in 26 patients with HCC and cirrhosis underwent RFA. Data was analyzed for safety and overall survival as the main endpoints. The mean age was 60.4 ± 11 years, 19 patients were male, 5 had hepatitis B virus, and 19 had hepatitis C virus. The Child classification was 26 per cent, 39 per cent, and 35 per cent for A, B, and C; the number of lesions was 1 in 62 per cent, 2 in 23 per cent, and more than 2 in 15 per cent. The approach was laparoscopic in 58 per cent, percutaneous in 15 per cent, and open in 27 per cent. There were no mortalities and only 1 complication. Average hospital stay was 2.7 ± 2 days. Subsequent to RFA, 9 patients underwent an OLT within a median of 4.1 months. The median follow-up of the whole group was 13 months and the disease-free survival 9.3 months. Tumor recurrence was identified in 3 previously ablated lesions, nonablated liver in 11, and as pulmonary metastases in 3. Overall survival (P = 0.03) was prolonged for those treated with RFA + OLT over RFA alone. We conclude that RFA is a safe ablative technique in high-risk cirrhotic patients with HCC. This technique may provide a bridge to OLT; however, it remains to be proven whether it prolongs survival in those who do not undergo OLT.


Related Articles

  • Factors associated with recurrence and survival in liver transplant patients with HCC - a single center retrospective study. Hoyos, Sergio; Escobar, Jorge; Cardona, Doris; Guzmán, Carlos; Mena, Álvaro; Osorio, Germán; Pérez, Camilo; Restrepo, Juan C.; Correa, Gonzalo // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2015, Vol. 14 Issue 1, p58 

    Introduction. Hepatocellular carcinoma is the most common primary tumor of the liver and is diagnosed in more than a half million people worldwide each year. This study aims to assess factors associated with the recurrence and survival of patients with hepatocellular carcinoma and liver...

  • Hepatitis C virus: current concepts and future challenges. Klenerman, P.; Gupta, P.K. // QJM: An International Journal of Medicine;Jan2012, Vol. 105 Issue 1, p29 

    No abstract available.

  • A Disease-Based Comparison of Liver Transplantation Outcomes. MAILEY, BRIAN; BUCHBERG, BRIAN; PRENDERGAST, CHRISTIE; ARTINYAN, AVO; KHALILI, JOSHUA; SANCHEZ-LUEGE, NICELIO; COLQUHOUN, STEVEN D.; KIM, JOSEPH // American Surgeon;Oct2009, Vol. 75 Issue 10, p901 

    An increasing demand for transplant donor organs has made optimal allocation of resources a priority. Our objective was to evaluate outcomes for orthotopic liver transplantation (OLT) performed in the United States. A query of the United Network for Organ Sharing registry between 1988 and 2007...

  • Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. Kenji Ikeda; Yasuji Arase; Masahiro Kobayashi; Satoshi Saitohi, Marisa; Takashi Someya; Tetsuya Hosaka; Yoshiyuki Suzuki; Fumitaka Suzuki; Akihito Tsubota; Norio Akuta; Hiromitsu Kumada // Journal of Gastroenterology;2003, Vol. 38 Issue 9, p865 

    Background. Tumor recurrence is common after potentially curative ablation of hepatocellular carcinoma; therefore, the incidence of intrahepatic metastasis and multicentric carcinogenesis was evaluated. Methods. A cohort of 892 patients with cirrhosis caused by either hepatitis B virus (n =246)...

  • RNA interference-mediated prevention and therapy for hepatocellular carcinoma. Romano, P. R.; McCallus, D. E.; Pachuk, C. J. // Oncogene;6/26/2006, Vol. 25 Issue 27, p3857 

    Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death and is on the increase worldwide. Hepatocellular carcinoma results from chronic liver disease and cirrhosis most commonly associated with chronic hepatitis B (HBV) or hepatitis C (HCV) infection. The highest...

  • Pathogenesis of Hepatocellular Carcinoma. Caselmann, Wolfgang H. // Digestion;1998 Supplement 2, Vol. 59, p60 

    Hepatocellular carcinoma (HCC) represents about 4% of all malignancies worldwide. There are up to 1 million new cases per year and its relative frequency is increasing. Hepatocarcinogenesis is a multistep process and a multifactorial event. The major risk factors for HCC development have been...

  • Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Rehermann, Barbara // Nature Medicine;Jul2013, Vol. 19 Issue 7, p859 

    Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for 57% of cases of liver cirrhosis and 78% of cases of primary liver cancer worldwide and cause a million deaths per year. Although HBV and HCV differ in their genome structures, replication strategies and life...

  • Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance. Trevisani, Franco; Magini, Giulia; Santi, Valentina; Morselli-Labate, Antonio Maria; Chiara Cantarini, Maria; Anna Di Nolfo, Maria; Del Poggio, Paolo; Benvegn, Luisa; Rapaccini, Gianludovico; Farinati, Fabio; Zoli, Marco; Borzio, Franco; Giovanni Giannini, Edoardo; Caturelli, Eugenio; Bernardi, Mauro // American Journal of Gastroenterology;May2007, Vol. 102 Issue 5, p1022 

    OBJECTIVES: Although the etiology of liver disease affects the features of hepatocellular carcinoma (HCC) diagnosed during surveillance, it is not known whether it influences patients' survival. We analyzed the impact of etiology on the characteristics and outcome of HCC detected during...

  • Natural History of Hepatitis B and C Virus Infections. Iino, Shiro // Oncology;2002 Supplement 1, Vol. 62, p18 

    Thirty-five years have already elapsed since the discovery of hepatitis B virus (HBV), and 10 years since that of hepatitis C virus (HCV). Nonetheless, the natural history of HBV and HCV infections has not been fully defined, partly because they do not have subjective symptoms in most cases....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics